Tag Archives: Recent

Weekly Roundup for MARCH 22, 2019: Recent Publications in Women’s Mental Health

The excitement over the FDA approval of brexanolone (to be marketed as Zulresso) is a good place to start this week’s roundup.  Brexanolone is a derivative of the neurosteroid allopregnanolone, and, while Zulpresso was approved specifically for the treatment of postpartum depression, there is considerable research to indicate that the modulation of neurosteroid systems may… Read More »

Weekly Roundup for MARCH 8, 2019: Recent Publications in Women’s Mental Health

This week another study highlights the importance of prenatal vitamins in reducing the risk of autism spectrum disorders (ASD).  This study from Schmidt and colleagues focused on high-risk families. In these families, one child had already been diagnosed with ASD.  The risk of having a child with ASD in subsequent children was cut in half… Read More »